Getting The Deal Through logo
Getting The Deal Through

AFT Pharma ads “false and misleading”, says Australian Federal Court

Pharma - News – 30 October 2018

An Australian judge has ruled that New Zealand’s AFT Pharmaceuticals made “misleading or deceptive” claims in adverts for its Maxigesic pain relief drug.

Cravath advises Novartis on US$2.1bn biopharma buyout

Pharma - News – 23 October 2018

A team from Cravath Swaine & Moore is advising Novartis on its US$2.1 billion acquisition of US cancer treatment developer Endocyte.

Community round-up: One in two out at Sidley, Dechert hires from Hughes Hubbard

Pharma - News – 23 October 2018

Recent weeks have seen Sidley Austin shed two life sciences patent litigators in New York shortly after hiring a new transactional specialist on the West Coast. Dechert, meanwhile, has added to its own IP disputes team with a hire from Hughes Hubbard & Reed.

ECJ finds public procurement controls apply to Italian drug distribution contract

Pharma - News – 23 October 2018

A drug distribution contract awarded by an Italian local health authority to a Catholic hospital is still subject to EU regulations on public works contracts, despite a national court ruling that both parties are classified as “public” institutions under Italian law and are shielded from the rules, the European Court of Justice has said.

Brexit deal “urgently needed” for medicine, ABPI tells MPs

Pharma - News – 16 October 2018

The Association of the British Pharmaceutical Industry (ABPI) has told UK MPs that the country “urgently needs” to strike a deal with the EU to fully protect its patients.

EU patent carve-outs for generics block regulators from publishing leaflets, advocate general says

Pharma - News – 16 October 2018

National regulators should publish limited versions of drug labels and summaries under EU laws that allow generic companies to market drugs before some of their approved indications come off patent, an advocate general of the European Court of Justice has said.

Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn